Hypromellose, Unspecified & SUCROSE Excipient Use in Transmucosal Dosage Forms

Hypromellose, Unspecified

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

9 Listed Products, 1 Pfanstiehl, 1 Actylis, 1 Gangwal Chemicals, 6 Seppic

REGULATORY FILINGS

7 Suppliers, 7 USDMF, 3 NDC API

SOLUTIONS BY APPLICATIONS

8 Coating Systems & Additives, 2 Coloring Agents, 2 Thickeners and Stabilizers, 2 Taste Masking, 1 Parenteral

REF. STANDARDS & IMPURITIES

3 Others

3 Others

FINISHED FORMULATIONS

629 ORAL, 145 TABLET, 82 CAPSULE, EXTENDED RELEASE, 67 SOLUTION, 66 FOR SUSPENSION, 54 CAPSULE, 52 CAPSULE, DELAYED REL PELLETS, 50 SYRUP, 41 SUSPENSION, 18 TABLET, EXTENDED RELEASE, 14 INJECTABLE, 13 CAPSULE, DELAYED RELEASE, 12 INJECTION, 11 POWDER, 9 FOR SOLUTION, 9 SUSPENSION, EXTENDED RELEASE, 8 INTRAVENOUS, 8 TABLET, CHEWABLE, 7 ORAL-28, 6 ORAL-21, 6 TABLET, DELAYED RELEASE, 5 TABLET, ORALLY DISINTEGRATING, 4 GRANULE, 4 VIAL, 3 ELIXIR, 3 SUBCUTANEOUS, 2 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 2 CONCENTRATE, 2 FOR SUSPENSION, EXTENDED RELEASE, 2 INJECTABLE, LIPOSOMAL, 2 SUSPENSION/DROPS, 2 TRANSMUCOSAL, 2 TROCHE/LOZENGE, 1 EMULSION, 1 INTRAVENOUS, SUBCUTANEOUS, 1 IV (INFUSION), 1 NASAL, 1 POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER, 1 SINGLE-USE, 1 SPRAY, METERED, 1 SUBCUTANEOUS LYOPHILIZED POWER, 1 SYRINGE